* known allergy to any vaccine component * history of severe allergic reaction that required medical intervention * thrombocytopenia or any coagulation disorder * has a history of myocarditis or pericarditis * has a history of a clinical or microbiological diagnosis of covid-19 ≤90 days prior to day 1 visit or history of multisystem inflammatory syndrome in children (mis-c) at any time prior to day 1 visit * females only: participant is pregnant * currently immunocompromised, or been diagnosed with immunodeficiency * had a splenectomy * receiving or has received immunosuppressive therapies within the last year * received any immunoglobulin product or blood-derived product within 3 months * received a marketed hpv vaccine or has participated in an hpv vaccine clinical trial

* known allergy to any vaccine component * history of severe allergic reaction that required medical intervention * thrombocytopenia or any coagulation disorder * has a history of myocarditis or pericarditis * has a history of a clinical or microbiological diagnosis of covid-19 ≤90 days prior to day 1 visit or history of multisystem inflammatory syndrome in children (mis-c) at any time prior to day 1 visit * females only: participant is pregnant * currently immunocompromised, or been diagnosed with immunodeficiency * had a splenectomy * receiving or has received immunosuppressive therapies within the last year * received any immunoglobulin product or blood-derived product within 3 months * received a marketed hpv vaccine or has participated in an hpv vaccine clinical trial

known allergy to any vaccine component history of severe allergic reaction that required medical intervention thrombocytopenia or any coagulation disorder has a history of myocarditis or pericarditis has a history of a clinical or microbiological diagnosis of covid-19 ≤90 days prior to day 1 visit or history of multisystem inflammatory syndrome in children (mis-c) at any time prior to day 1 visit females only: participant is pregnant currently immunocompromised, or been diagnosed with immunodeficiency had a splenectomy receiving or has received immunosuppressive therapies within the last year received any immunoglobulin product or blood-derived product within 3 months received a marketed hpv vaccine or has participated in an hpv vaccine clinical trial

known allergy to any vaccine component history of severe allergic reaction that required medical intervention thrombocytopenia or any coagulation disorder has a history of myocarditis or pericarditis has a history of a clinical or microbiological diagnosis of covid-19 ≤90 days prior to day 1 visit or history of multisystem inflammatory syndrome in children (mis-c) at any time prior to day 1 visit females only: participant is pregnant currently immunocompromised, or been diagnosed with immunodeficiency had a splenectomy receiving or has received immunosuppressive therapies within the last year received any immunoglobulin product or blood-derived product within 3 months received a marketed hpv vaccine or has participated in an hpv vaccine clinical trial

known allergy to any vaccine component history of severe allergic reaction that required medical intervention thrombocytopenia or any coagulation disorder has a history of myocarditis or pericarditis has a history of a clinical or microbiological diagnosis of covid-19, including a diagnosis of multisystem inflammatory syndrome in children females only: participant is pregnant or expecting to donate eggs during day 1 through month 7 currently immunocompromised, or been diagnosed with immunodeficiency had a splenectomy receiving or has received immunosuppressive therapies within the last year received any immunoglobulin product or blood-derived product within 3 months received a marketed hpv vaccine or has participated in an hpv vaccine clinical trial

known allergy to any vaccine component history of severe allergic reaction that required medical intervention thrombocytopenia or any coagulation disorder has a history of myocarditis or pericarditis has a history of a clinical or microbiological diagnosis of covid-19, including a diagnosis of multisystem inflammatory syndrome in children females only: participant is pregnant or expecting to donate eggs during day 1 through month 7 currently immunocompromised, or been diagnosed with immunodeficiency had a splenectomy receiving or has received immunosuppressive therapies within the last year received any immunoglobulin product or blood-derived product within 3 months received a marketed hpv vaccine or has participated in an hpv vaccine clinical trial